Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian High Grade Serous Adenocarcinoma 1 Medulloblastoma 1 Locally Advanced Non-Small Cell Lung Cancer 1 Leukemia, Myeloid, Acute 1 Hypoxia 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 20 Etoposide 19 Temozolomide 16 Carboplatin 16 Filgrastim 15 Vincristine 11 Cisplatin 11 Radiotherapy 10 Thiotepa 9 Melphalan 8 Granulocyte Colony-Stimulating Factor 8 etoposide phosphate 7 Lomustine 7 Peripheral Blood Stem Cell Transplantation 6 Radiation 5 Methotrexate 5 Magnetic Resonance Spectroscopy 5 Topotecan 4 Mesna 4 Gemcitabine 4 Busulfan 4 sargramostim 3 gallium Ga 68 dotatate 3 Thalidomide 3 Stem Cell Transplantation 3 Irinotecan 3 Ifosfamide 3 Donepezil 3 Celecoxib 3 Automobiles 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Medulloblastoma × Atovaquone × Clear all

NCT06624371 2025-07-22

AflacBT2303

Emory University

Phase 1 Recruiting

Diffuse Intrinsic Pontine Glioma, Glioma, Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡